Journals / Turkish Neurosurgery / 2013 / Cilt: 23 - Sayı: 2

Atipik Hipofiz Adenomu Olgularının İnsidansı, Hormonal Dağılımı ve Postoperatif Takibi

Incidence, Hormonal Distribution and Postoperative Follow Up of Atypical Pituitary Adenomas

Pages
226–231
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In our opinion, if total resection is not possible for the patients with APA, close postoperative follow up and additional curative therapy modalities are needed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:AIM: To assess the incidence, hormonal activity and postoperative follow up of the cases that are histopathologically diagnosed as atypical pituitary adenoma (APA) in our series.
📊
Key Findings & Data:MATERIAL and METHODS: In this study, 13 atypical pituitary adenoma cases, by the WHO 2004 criteria, among the 146 pituitary adenoma patients operated on in our clinic between January 2009 and May 2012 by endoscopic endonasal transsphenoidal approach were included. results: In histological studies, 133 cases were diagnosed as typical pituitary adenoma (91.1%) and 13 cases were APAs (8.9%) of which 10 were male (76.9%) and 3 were female (23.1%), ranged between 27 and 80 (mean 52.7) ages.
💡
Conclusion & Impact:In our opinion, if total resection is not possible for the patients with APA, close postoperative follow up and additional curative therapy modalities are needed.
🔬Design:Research Article
📍Scope:2004 Verileri
⚙️Variables:Domain Parameters

Abstract

AIM: To assess the incidence, hormonal activity and postoperative follow up of the cases that are histopathologically diagnosed as atypical pituitary adenoma (APA) in our series. MATERIAL and METHODS: In this study, 13 atypical pituitary adenoma cases, by the WHO 2004 criteria, among the 146 pituitary adenoma patients operated on in our clinic between January 2009 and May 2012 by endoscopic endonasal transsphenoidal approach were included. results: In histological studies, 133 cases were diagnosed as typical pituitary adenoma (91.1%) and 13 cases were APAs (8.9%) of which 10 were male (76.9%) and 3 were female (23.1%), ranged between 27 and 80 (mean 52.7) ages. Histopathological distribution of APAs was 9 non- secretory adenomas (69.3%), 3 prolactinomas (23.1%) and 1 somatostatinoma (7.6%). Asymptomatic pituitary apoplexy was diagnosed in 4 cases (30.7%). Eleven cases of typical pituitary adenomas (8.2%) and 5 cases of the atypical pituitary adenomas (38.4%) were re-operated due to tumor recurrences. CONCLUSION: Accurate histopathological examination shows that atypical pituitary adenoma is not a rare disease. Although it is not the only determinant, APAs are more prone to recurrence than typical adenomas. In our opinion, if total resection is not possible for the patients with APA, close postoperative follow up and additional curative therapy modalities are needed.

Özet

AMAÇ: Hipofiz adenomu tanısı ile operasyon uygulanan olgularımızdan patoloj ik tanısı atipik hipofiz adenomu olanların görülme sıklığı, hormonal aktivitesi ve postoperatif takipleri araştırılmıştır. YÖNTEM ve GEREÇlER: Kliniğimizde Ocak 2009 - Mayıs 2012 tarihleri arasında endoskopik endonasal transsfenoidal yolla opere edilen 146 hipofiz adenomu olgusundan WHO 2004 kriterlerine göre patoloj isi atipik hipofiz adenomu olarak saptanan 13 olgu çalışmaya dahil edildi. BUlGULAR: Histoloj ik olarak 133 hasta tipik hipofiz adenomu (%91,1), 13 hasta ise atipik hipofiz adenomu (%8,9) idi. Bu hastaların 10 tanesi erkek (%76,9), 3 tanesi kadındı (%23,1). Yaş dağılımı 27 ile 80 arasında idi (ortalama 52.7). Dokuz olgu nonsekretuar adenom (%69,3), 3 olgu prolaktinoma (%23,1), 1 olgu ise somatostatinoma (%7,6) idi. Dört olguda hipofizer apopleksi mevcuttu (%30,7). Tipik hipofiz adenomlu hastalardan 11 tanesinde nüks saptanırken (%8,2), atipik hipofiz adenomlu olgulardan ise 5 tanesinde nüks adenom (%38,4) nedeniyle tekrar operasyon yapıldı. SONUÇ: Atipik hipofiz adenomları iyi bir patoloj ik inceleme yapıldığında çok da nadir görülen adenom tipi değildir. Tümör rekürrensinde tek başına belirleyici olmamakla birlikte tipik adenomlara göre çok daha yüksek oranda rekürrense neden olduğu unutulmamalıdır. Bu yüzden bu hastalarda total tümör eksizyonu, eğer mümkün olmuyorsa postoperatif daha yakın takip ile ek tedavi uygulamalarının kullanılması gereklidir.

🔖

Cite This Article

YILDIRIM, A. E., DIVANLIOGLU, D., NACAR, O. A., DURSUN, E., ŞAHİNOĞLU, M., ÜNAL, T., BELEN, A. D. (2013). Atipik Hipofiz Adenomu Olgularının İnsidansı, Hormonal Dağılımı ve Postoperatif Takibi. Turkish Neurosurgery, Cilt: 23 - Sayı: 2, 226–231. https://ajindex.com/articles/404920

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Mamelak AN, Carmichael JD, Park P, Bannykh S, Fan X, Bonert HV: Atypical pituitary adenoma with malignant features. Pituitary 14: 92–97, 2011 2. Burrow GN, Wortzman G, Rewcastle NB, Holgate RC, Kovacs K: Microadenomas of the pituitary and abnormal sellar tomograms in an unselected autopsy series. N Engl J Med 304:156-158, 1981 3. DeLellis RA, Lloyd RV, Heitz PU, Eng C (Eds): World Health Organization Classification of tumors. Pathology and genetics of tumors of endocrine organs. Lyon: IARC Pres, 2004:10-35 4. Elster AD: Modern imaging of the pituitary. Radiology 187: 1-14, 1993 5. Ertan Y, Sarsik B, Akalin T: Tipik ve atipik hipofiz adenomlarında hormon immunreaktivite dağılımı. Turkish Journal of Pathol- ogy 25: 106-111, 2009 6. Figarella-Branger D, Trouillas J: The new WHO Classification of human pituitary tumors: Comments. Acta Neuropathol 111: 71–72, 2006 7. Grossman AB: The 2004 World Health Organization Classification of Pituitary Tumors: Is it clinically helpful? Acta Neuropathol 111: 76–77, 2006 8. Kleinschmidt-DeMasters BK: Subtyping does matter in pituitary adenomas. Acta Neuropathol 111: 84–85, 2006 9. Kontogeorgos G: Innovations and controversies in the WHO Classification of Pituitary Adenomas. Acta Neuropathol 111: 73–75, 2006 10. Kovacs K, Scheithauer BW, Horvath E, Lloyd RV: The World Health Organization Classification of Adenohypophysial Neo- plasms. A proposed five-tier scheme. Cancer 78: 502–510, 1996 11. Kovacs K: The 2004 WHO Classification of Pituitary Tumors: Comments. Acta Neuropathol 111: 62–63, 2006 12. Laws ER Jr, Lopes MB: The new WHO Classification of Pituitary Tumors: Highlights and areas of controversy. Acta Neuropathol 111: 80–81, 2006 13. Ogawa Y, Ikeda H, Tominaga T: Clinicopathological study of prognostic factors in patients with pituitary adenomas and Ki-67 labeling index of more than 3%. J Endocrinol Invest 7: 581–584, 2009 14. Saeger W, Lüdecke DK, Buchfelder M, Fahlbusch R, Quabbe HJ, Petersenn S: Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry. Eur J Endocrinol 156: 203–216, 2007 15. Scheithauer BW, Gaffey TA, Lloyd RV, Sebo TJ, Kovacs KT, Horvath E, Yapicier O, Young WF Jr, Meyer FB, Kuroki T, Riehle DL, Laws ER Jr: Pathobiology of pituitary adenomas and carcinomas. Neurosurgery 59:341-353, 2006 16. Thapar K, Kovacs K, Scheithauer BW, Stefaneanu L, Horvath E, Pernicone PJ: Proliferative activity and invasiveness among pituitary adenomas and carc